NCT04006886View on ClinicalTrials.gov

Gluten-free Diet in Patients With Primary Sclerosing Cholangitis (PSC)

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 11, 2017

Primary Completion Date

May 9, 2019

Study Completion Date

July 1, 2019

Conditions
Reduction of Intestinal Inflammatory Activity
Interventions
DIETARY_SUPPLEMENT

Gluten-free diet

After run-in phase with normal diet under Observation, patients will be on a gluten-free diet for two months.

Trial Locations (1)

22081

University Medical Center Hamburg-Eppendorf, Hamburg

All Listed Sponsors
collaborator

Institute for Clinical Molecular Biology, Christian-Albrechts-University, Kiel

UNKNOWN

collaborator

Johannes Gutenberg University Mainz

OTHER

lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT04006886 - Gluten-free Diet in Patients With Primary Sclerosing Cholangitis (PSC) | Biotech Hunter | Biotech Hunter